Holdings of State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST
· 59 declared positions · as of Mar 31, 2026
Original filing · Net assets 307.9M $ · Ten largest lines: 20.9 % of the equity sleeve
Sector breakdown Health care 9.6 % Unattributed 90.4 % Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown US 93.0 % IE 4.1 % CA 1.9 % SG 1.0 % Shares computed on the equity sleeve, the only part this site carries.
Country Lines Value Share US 55 286.1M $ 93.01 % IE 2 12.5M $ 4.06 % CA 1 6M $ 1.95 % SG 1 3M $ 0.99 %
Positions Company Shares Value Weight Enliven Therapeutics Inc 192,297 7.5M $ 2.45 % Corcept Therapeutics Inc 174,971 7.1M $ 2.29 % Terns Pharmaceuticals Inc 126,197 6.7M $ 2.16 % Perrigo Co PLC 601,785 6.5M $ 2.10 % Axsome Therapeutics Inc 37,013 6.3M $ 2.03 % Innoviva Inc 263,314 6.1M $ 1.99 % Merck & Co Inc 50,800 6.1M $ 1.98 % Pfizer Inc 216,247 6.1M $ 1.97 % Royalty Pharma PLC 126,441 6.1M $ 1.97 % Elanco Animal Health Inc 251,749 6M $ 1.96 % Jazz Pharmaceuticals PLC 31,838 6M $ 1.96 % Esperion Therapeutics Inc 2,194,800 6M $ 1.95 % Edgewise Therapeutics Inc 190,497 6M $ 1.95 % MBX Biosciences Inc 200,744 6M $ 1.95 % Definium Therapeutics Inc 316,882 6M $ 1.95 % Bristol-Myers Squibb Co 98,425 6M $ 1.94 % ANI Pharmaceuticals Inc 77,382 6M $ 1.93 % Johnson & Johnson 24,295 5.9M $ 1.93 % Tarsus Pharmaceuticals Inc 84,481 5.9M $ 1.93 % Trevi Therapeutics Inc 494,432 5.9M $ 1.92 % Pacira BioSciences Inc 258,586 5.8M $ 1.90 % Zoetis Inc 49,282 5.8M $ 1.89 % Crinetics Pharmaceuticals Inc 159,642 5.8M $ 1.88 % Nektar Therapeutics 80,506 5.8M $ 1.88 % Liquidia Corp 153,099 5.8M $ 1.88 % Amneal Pharmaceuticals Inc 464,477 5.8M $ 1.88 % Harmony Biosciences Holdings Inc 205,054 5.7M $ 1.87 % Supernus Pharmaceuticals Inc 110,926 5.7M $ 1.86 % Viatris Inc 422,585 5.7M $ 1.85 % Xeris Biopharma Holdings Inc 975,649 5.7M $ 1.84 % Harrow Inc 159,813 5.6M $ 1.83 % Organon & Co 922,423 5.5M $ 1.79 % Nuvation Bio Inc 1,286,168 5.5M $ 1.79 % Phibro Animal Health Corp 99,625 5.5M $ 1.79 % Amylyx Pharmaceuticals Inc 395,413 5.5M $ 1.79 % Indivior Pharmaceuticals Inc 179,821 5.5M $ 1.78 % Collegium Pharmaceutical Inc 165,736 5.5M $ 1.78 % Eli Lilly & Co 5,904 5.4M $ 1.76 % Prestige Consumer Healthcare Inc 91,089 5.4M $ 1.75 % Ligand Pharmaceuticals Inc 26,684 5.3M $ 1.73 % Ocular Therapeutix Inc 621,423 5.3M $ 1.71 % Omeros Corp 494,846 5.2M $ 1.70 % EyePoint Inc 395,677 5.1M $ 1.66 % Alumis Inc 224,127 4.9M $ 1.60 % Amphastar Pharmaceuticals Inc 227,681 4.5M $ 1.45 % Phathom Pharmaceuticals Inc 398,901 4.4M $ 1.44 % Theravance Biopharma Inc 268,815 4.4M $ 1.42 % Rapport Therapeutics Inc 134,504 4.2M $ 1.37 % Arvinas Inc 362,073 3.8M $ 1.25 % CorMedix Inc 554,307 3.8M $ 1.22 % BioAge Labs Inc 210,974 3.7M $ 1.20 % Maze Therapeutics Inc 117,041 3.5M $ 1.13 % Septerna Inc 128,633 3.1M $ 1.00 % WaVe Life Sciences Ltd 419,283 3M $ 0.99 % Zevra Therapeutics Inc 324,871 3M $ 0.98 % Fulcrum Therapeutics Inc 367,717 2.8M $ 0.92 % Aquestive Therapeutics Inc 600,305 2.5M $ 0.81 % LB Pharmaceuticals Inc 89,202 2.2M $ 0.71 % Alto Neuroscience Inc 73,288 1.6M $ 0.54 %